Ohio Innovation Fund

Ohio Innovation Fund is a venture capital firm based in Columbus, Ohio, specializing in early-stage and startup investments. Founded in 2016, the firm focuses on the technology sector, with particular interest in medical technology, biopharma, augmented and virtual reality, advanced manufacturing, software as a service, artificial intelligence, machine learning, cybersecurity, and mobility. Ohio Innovation Fund primarily invests in companies located in Ohio, typically providing funding between $250,000 and $500,000, with the potential for up to $1.25 million based on specific milestones achieved by the companies.

Michael Hughes

Venture Partner

Jill Raderstorf

Partner

Faith Voinovich

Principal

39 past transactions

Niobium Microsystems

Seed Round in 2024
Niobium Microsystems specializes in developing custom integrated circuits and microelectronic systems tailored for clients facing complex power, performance, and security challenges. The company focuses on high-performance microelectronic components that facilitate the secure collection, processing, and distribution of critical data. Notably, Niobium Microsystems has designed a complete system-on-chip (SoC) for fully homomorphic encryption (FHE), which enhances data security while providing semiconductor solutions. Through its innovative offerings, the company aims to help clients safeguard their data effectively.

Trace

Pre Seed Round in 2024
Trace is the Canva for AR. The simplest way ever to make AR recordings and experiences for brands, retail, training and more. Partners include teams at Qualcomm, Deutsche Telekom, Lenovo, Telefonica and other fortune 500 companies. Contact us to work together or learn more. Info@Trace3d.app

Clarametyx Biosciences

Series A in 2024
Clarametyx Biosciences, Inc. is a biotechnology company based in Columbus, Ohio, focused on developing targeted and immune-enabling biologic therapies to address persistent infections linked to biofilms. Founded in 2020, the company utilizes a novel technology platform designed to penetrate the protective layers surrounding bacteria, facilitating immune responses and enhancing the effectiveness of antibiotic interventions. Among its key developments is CMTX-001, a humanized monoclonal antibody currently in preclinical stages aimed at treating hospital-acquired pneumonia. Clarametyx's innovative approach seeks to combat life-threatening infections while addressing the growing concerns of antibiotic resistance.

Lentechs

Venture Round in 2023
Lentechs is a medical device company based in Columbus, Ohio, specializing in the development of innovative soft bifocal contact lenses. The company focuses on creating a new generation of soft, suspended progressive contact lenses that enhance visual clarity and comfort. These lenses are designed to allow natural eye movement, similar to the experience of wearing bifocal glasses, while minimizing irritation. Lentechs aims to provide a comprehensive range of products that address the needs of patients throughout their visual health journey.

AKRU

Seed Round in 2022
AKRU is a commercial real estate investment platform that utilizes blockchain technology to facilitate fractional ownership of real estate assets. By offering security tokens, the platform allows investors to participate with a minimum investment of $1,000. This innovative approach not only enhances accessibility but also significantly shortens the transaction cycle, enabling instant recording of transactions on an immutable ledger. This feature fosters trust among investors and provides them with greater control and liquidity over their investments. Since its beta launch in October 2020, AKRU has successfully secured 14 assets and attracted over 50 investors. The platform was relaunched in March 2021 as a prominent sponsor for the Security Token Summit, further establishing its presence in the industry. AKRU has garnered attention from various major publications, highlighting its role in modernizing real estate investment.

Genetesis

Series C in 2022
Genetesis LLC is a medical technology company based in Mason, Ohio, that specializes in biomagnetic imaging solutions to improve patient diagnosis and monitoring of cardiac conditions. Founded in 2013, the company has developed the Genetesis CardioFlux, a mapping system designed to enhance the detection and treatment of cardiac rhythm disorders by visualizing the heart's electrical currents in three dimensions. Additionally, Genetesis offers the Faraday Analytical Cloud, a HIPAA-compliant platform that manages the data workflow for the CardioFlux magnetocardiograph. The system is non-invasive and avoids exposing patients to radiation or requiring exercise, enabling clinicians to accurately measure the magnetic signals generated by the heart during its electrical activity.

Enable Injections

Series C in 2022
Enable Injections, LLC specializes in the design and manufacture of disposable, body-worn bolus injectors that facilitate the delivery of high viscosity and volume injectable drugs directly into subcutaneous tissue. Established in 2010 and based in Cincinnati, Ohio, the company’s innovative devices can utilize standard containers such as vials, syringes, or cartridges. These injectors not only allow for the reconstitution of powdered drugs but also enable the delivery of up to 20 ml of medication. The system automatically warms and mixes lyophilized solutions, ensuring a seamless injection experience. Additionally, Enable Injections offers a version of its platform that can connect to smartphones via Bluetooth, enhancing user interaction. With approximately 900 new drugs in development that may benefit from this technology, the market for bolus injection systems is projected to reach $8 billion within the next decade.

Aware

Series C in 2021
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.

DAtAnchor

Convertible Note in 2021
Traditional IT controls focus on locking down networks, devices, and people. All of this is done in the name of protecting data. But, once files are moved, shared, or stolen, the data is no longer protected. Even worse, these controls get in the way and frustrate business users to the point they intentionally work around them. Anchor inverts the equation by baking protection into the data, invisible to the business users (like antivirus), so that files are free to travel and security is out of the way. Simply put, wherever the data goes, it is protected. Anchor is a SaaS platform, with an endpoint component, that bakes protection into your files with a unique transparent combination of encryption, continuous multi-factor access controls, and a digital chain of custody. And when you do share or collaborate, Anchor protection stays with your data, even when it leaves your organization. Anchor empowers you to maintain control of your files while collaborating on premise or in the cloud, including forensic logging and revoking access. In under 90 minutes, Anchor is fully deployed and empowers your business users to securely work and collaborate without complicated security products or rules in the way. All without requiring you to change existing IT controls or how your users and applications work today. DAtAnchor is a result of a multi-year research activity, developed at Ohio State University. The development team currently has 6 members, 4 of which are full-time. We have seed level funding for >1M and an advisory board with members at the senior vice president level in Fortune 500 companies.

S4 Medical

Series A in 2021
S4 Medical Corp. is a medical device company based in Cleveland, Ohio, founded in 2017. The company specializes in developing innovative solutions for catheter ablation treatment, specifically targeting atrial fibrillation. Its primary product, the eSolution device, is designed to minimize complications to the esophagus during ablation procedures. This device allows healthcare providers to protect the esophagus and aids electrophysiologists in determining the necessary adjustments for effective treatment. S4 Medical's focus on enhancing patient safety in cardiac procedures reflects its commitment to improving outcomes in the field of electrophysiology.

eFuse

Venture Round in 2021
eFuse is a digital platform tailored for the esports and video game industry, founded in 2018 and based in Columbus, Ohio. It serves as a central hub for individuals to build their gaming identities and engage with the industry at various levels. The platform offers resources for learning about the gaming landscape, networking with peers, and accessing opportunities such as jobs and scholarships. Additionally, eFuse facilitates collaborations within the gaming community, focusing on player talent recruitment, job placement, and sponsorship sourcing. By providing these services, eFuse aims to enhance the overall experience for gamers and industry professionals alike.

Aware

Series B in 2020
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.

ScriptDrop

Series A in 2020
ScriptDrop’s technology platform enables connectivity across the healthcare ecosystem connecting patients, pharmacists, providers, and pharmaceutical manufacturers. The platform provides a seamless experience for patients, offering them prescription delivery in all 50 states and allowing for important additional services to be provided for better adherence. The company was founded in 2016 and is headquartered in Columbus, Ohio.

Immuta

Series C in 2020
Immuta, Inc. develops a data security platform that helps organizations manage data security, privacy, and access control. The platform offers automated data governance features, including sensitive data discovery, classification, and the ability to author security and access control policies without coding. It enables self-service access to data while providing visibility into data usage. Immuta's solution is utilized by a diverse range of sectors, including finance, healthcare, government, and manufacturing, for purposes such as cloud migration, regulatory compliance, and secure collaboration. Founded in 2015 and headquartered in Boston, Massachusetts, Immuta has established itself as a trusted partner for Fortune 500 companies and government agencies worldwide.

Genetesis

Series B in 2020
Genetesis LLC is a medical technology company based in Mason, Ohio, that specializes in biomagnetic imaging solutions to improve patient diagnosis and monitoring of cardiac conditions. Founded in 2013, the company has developed the Genetesis CardioFlux, a mapping system designed to enhance the detection and treatment of cardiac rhythm disorders by visualizing the heart's electrical currents in three dimensions. Additionally, Genetesis offers the Faraday Analytical Cloud, a HIPAA-compliant platform that manages the data workflow for the CardioFlux magnetocardiograph. The system is non-invasive and avoids exposing patients to radiation or requiring exercise, enabling clinicians to accurately measure the magnetic signals generated by the heart during its electrical activity.

S4 Medical

Venture Round in 2020
S4 Medical Corp. is a medical device company based in Cleveland, Ohio, founded in 2017. The company specializes in developing innovative solutions for catheter ablation treatment, specifically targeting atrial fibrillation. Its primary product, the eSolution device, is designed to minimize complications to the esophagus during ablation procedures. This device allows healthcare providers to protect the esophagus and aids electrophysiologists in determining the necessary adjustments for effective treatment. S4 Medical's focus on enhancing patient safety in cardiac procedures reflects its commitment to improving outcomes in the field of electrophysiology.

Able (formerly EmployStream)

Series B in 2020
EmployStream is a hiring workflow automation software platform for staffing companies and other high-volume employers. It also creates high-quality, user-friendly for high-volume employers that automates the hiring and onboarding process for employers. The platform eliminates costly mistakes and delays allowing companies to hire up to 90% faster and at half the cost. The company provides an online hiring platform which offers different features such as paper onboarding, real-time alerting, online application, background checks, applicant pre & interview screening, and verification. EmployStream was founded in 2014 and is headquartered in Cleveland Ohio, USA.

Windpact

Venture Round in 2019
Windpact, Inc. is a provider of impact protection solutions that cater to various sectors, including sports, military, automotive, construction, and medical applications. Founded in 2011 and based in Leesburg, Virginia, the company offers a platform as a service that enables product development teams to explore innovative foam solutions. Windpact's technology incorporates machine learning, finite element analysis (FEA) modeling, and a unique Crash Cloud system, which dynamically adjusts to various impact rates, ensuring effective protection for individuals at risk of impact. Additionally, Windpact develops software tools that assist product developers throughout the growth stages, featuring capabilities such as an auto-packer for three-dimensional manufacturing and design optimization. These tools aim to enhance design timelines and reduce development costs, enabling designers to achieve optimal performance aligned with their product objectives.

eFuse

Seed Round in 2019
eFuse is a digital platform tailored for the esports and video game industry, founded in 2018 and based in Columbus, Ohio. It serves as a central hub for individuals to build their gaming identities and engage with the industry at various levels. The platform offers resources for learning about the gaming landscape, networking with peers, and accessing opportunities such as jobs and scholarships. Additionally, eFuse facilitates collaborations within the gaming community, focusing on player talent recruitment, job placement, and sponsorship sourcing. By providing these services, eFuse aims to enhance the overall experience for gamers and industry professionals alike.

Able (formerly EmployStream)

Series A in 2019
EmployStream is a hiring workflow automation software platform for staffing companies and other high-volume employers. It also creates high-quality, user-friendly for high-volume employers that automates the hiring and onboarding process for employers. The platform eliminates costly mistakes and delays allowing companies to hire up to 90% faster and at half the cost. The company provides an online hiring platform which offers different features such as paper onboarding, real-time alerting, online application, background checks, applicant pre & interview screening, and verification. EmployStream was founded in 2014 and is headquartered in Cleveland Ohio, USA.

Complion

Series B in 2019
Complion Inc. is a developer of a web-based document and workflow management platform tailored for clinical research sites, academic medical centers, hospitals, health systems, and contract research organizations. The platform enables secure and compliant management of regulatory documents and administrative tasks, providing features such as document tracking, e-signatures, and real-time compliance insights. It facilitates various aspects of clinical trials, including study startup, amendment processing, safety reporting, and training, while ensuring high data security. Complion's solutions streamline information for auditors and quality assurance personnel, enhancing collaboration among researchers and sponsors. The company also offers customer support, training resources, and a searchable online help center to assist users. Founded in 2012 and headquartered in Cleveland, Ohio, Complion was previously known as RegBinder, Inc. before rebranding in 2013.

Stirling Ultracold

Series B in 2018
Stirling Ultracold, a division of Global Cooling, Inc., specializes in the development and manufacturing of ultra-low temperature freezers that operate below -86°C. These innovative freezers utilize patented free-piston Stirling engine technology, distinguishing them from traditional refrigeration methods that rely on dry ice, Peltier systems, or conventional cascade systems. Designed to meet the increasing needs of bio-repositories and pharmaceutical companies, Stirling Ultracold's products not only achieve stable storage conditions across a broad temperature range but also promote energy efficiency and environmental sustainability, allowing customers to realize significant energy savings while adhering to eco-friendly practices.

DAtAnchor

Seed Round in 2018
Traditional IT controls focus on locking down networks, devices, and people. All of this is done in the name of protecting data. But, once files are moved, shared, or stolen, the data is no longer protected. Even worse, these controls get in the way and frustrate business users to the point they intentionally work around them. Anchor inverts the equation by baking protection into the data, invisible to the business users (like antivirus), so that files are free to travel and security is out of the way. Simply put, wherever the data goes, it is protected. Anchor is a SaaS platform, with an endpoint component, that bakes protection into your files with a unique transparent combination of encryption, continuous multi-factor access controls, and a digital chain of custody. And when you do share or collaborate, Anchor protection stays with your data, even when it leaves your organization. Anchor empowers you to maintain control of your files while collaborating on premise or in the cloud, including forensic logging and revoking access. In under 90 minutes, Anchor is fully deployed and empowers your business users to securely work and collaborate without complicated security products or rules in the way. All without requiring you to change existing IT controls or how your users and applications work today. DAtAnchor is a result of a multi-year research activity, developed at Ohio State University. The development team currently has 6 members, 4 of which are full-time. We have seed level funding for >1M and an advisory board with members at the senior vice president level in Fortune 500 companies.

Enable Injections

Series B in 2018
Enable Injections, LLC specializes in the design and manufacture of disposable, body-worn bolus injectors that facilitate the delivery of high viscosity and volume injectable drugs directly into subcutaneous tissue. Established in 2010 and based in Cincinnati, Ohio, the company’s innovative devices can utilize standard containers such as vials, syringes, or cartridges. These injectors not only allow for the reconstitution of powdered drugs but also enable the delivery of up to 20 ml of medication. The system automatically warms and mixes lyophilized solutions, ensuring a seamless injection experience. Additionally, Enable Injections offers a version of its platform that can connect to smartphones via Bluetooth, enhancing user interaction. With approximately 900 new drugs in development that may benefit from this technology, the market for bolus injection systems is projected to reach $8 billion within the next decade.

Alviere

Series A in 2018
Alviere is a finance platform that offers embedded financial products and technology, allowing businesses to deliver a range of financial services to their customers. The platform facilitates banking, mobile payments, card issuance, payment processing, and cross-border currency exchange. By providing a flexible framework, Alviere enables brands to launch new financial service lines, thereby enhancing customer relationships and insights while boosting satisfaction and retention. This approach not only strengthens customer connections but also helps businesses increase revenue and maximize profits.

RXQ Compounding

Series A in 2018
RXQ Compounding, LLC is an FDA-approved 503B Outsourcing Facility located in Athens, Ohio, specializing in the manufacture and distribution of sterile and non-sterile medications throughout the United States. Founded in 2014, the company offers a diverse range of products including sterile and non-sterile injectables, veterinary medications, dermatologic creams and ointments, ophthalmic solutions, and orthopedic steroids, along with custom production solutions for hospitals. RXQ Compounding emphasizes safety and quality by adhering to rigorous regulatory standards and has developed a proprietary procedural manual to ensure compliance with FDA guidelines. The company's commitment to delivering reliable compounded drugs enables healthcare providers to access quality medications efficiently, ultimately supporting optimal patient outcomes.

Eccrine Systems

Series B in 2018
Eccrine Systems, Inc. specializes in the development of non-invasive, electronic wearable systems that monitor and transmit real-time data about human sweat. The company's flagship product, the Sweatronics platform, is a modular wearable system capable of measuring various analytes in sweat and wirelessly transmitting this data to remote applications. Eccrine's advanced sweat sensor technologies have applications across medicine, industry, and sports, facilitating the monitoring of biomarkers that can indicate dehydration, health issues, or the effectiveness of medications. Founded in 2013 and headquartered in Cincinnati, Ohio, the company collaborates with partners to translate its technology into market-ready products, enhancing the predictive value of non-invasive wearable data.

Mezu

Venture Round in 2018
Mezu, Inc., established in 2017 and based in Cleveland Heights, Ohio, operates in the banking industry with a focus on mobile payments. The company offers a secure and private mobile payment app that allows users to send and receive money without revealing personal information. This platform enables users to pay, tip, earn, and donate easily and at no cost, prioritizing user privacy and discretion in financial transactions. Mezu's app is accessible on both iOS and Android devices in the United States, reflecting its commitment to providing a cash-like experience in digital payments.

Genetesis

Series A in 2018
Genetesis LLC is a medical technology company based in Mason, Ohio, that specializes in biomagnetic imaging solutions to improve patient diagnosis and monitoring of cardiac conditions. Founded in 2013, the company has developed the Genetesis CardioFlux, a mapping system designed to enhance the detection and treatment of cardiac rhythm disorders by visualizing the heart's electrical currents in three dimensions. Additionally, Genetesis offers the Faraday Analytical Cloud, a HIPAA-compliant platform that manages the data workflow for the CardioFlux magnetocardiograph. The system is non-invasive and avoids exposing patients to radiation or requiring exercise, enabling clinicians to accurately measure the magnetic signals generated by the heart during its electrical activity.

Immuta

Series B in 2018
Immuta, Inc. develops a data security platform that helps organizations manage data security, privacy, and access control. The platform offers automated data governance features, including sensitive data discovery, classification, and the ability to author security and access control policies without coding. It enables self-service access to data while providing visibility into data usage. Immuta's solution is utilized by a diverse range of sectors, including finance, healthcare, government, and manufacturing, for purposes such as cloud migration, regulatory compliance, and secure collaboration. Founded in 2015 and headquartered in Boston, Massachusetts, Immuta has established itself as a trusted partner for Fortune 500 companies and government agencies worldwide.

ConnXus

Series A in 2018
ConnXus, Inc. is a provider of online services that connect diverse and small businesses with larger companies looking to enhance their supplier diversity. The company specializes in aggregating corporate purchasing demand, helping organizations locate, evaluate, and engage small, minority- or woman-owned businesses across various sectors, including construction, transportation, and information technology. ConnXus offers tools such as ConnXus Scrub, a data enrichment solution for validating supplier classifications, and TierTracker, a platform for reporting and management. Additionally, it features a diverse supplier search platform and a community marketplace that fosters networking and the sharing of best practices among supplier diversity professionals. ConnXus also assists registered suppliers in marketing their services and maintaining their certifications. Incorporated in 2010 and headquartered in Mason, Ohio, with a satellite office in Portland, Oregon, ConnXus serves Fortune 2000 and Fortune 500 companies and operates as a subsidiary of Coupa Software Incorporated.

Aware

Series A in 2018
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.

Immuta

Series A in 2017
Immuta, Inc. develops a data security platform that helps organizations manage data security, privacy, and access control. The platform offers automated data governance features, including sensitive data discovery, classification, and the ability to author security and access control policies without coding. It enables self-service access to data while providing visibility into data usage. Immuta's solution is utilized by a diverse range of sectors, including finance, healthcare, government, and manufacturing, for purposes such as cloud migration, regulatory compliance, and secure collaboration. Founded in 2015 and headquartered in Boston, Massachusetts, Immuta has established itself as a trusted partner for Fortune 500 companies and government agencies worldwide.

Aware

Series A in 2017
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.

Aware

Series A in 2017
Aware is a cloud intelligence platform that leverages advancements in cognitive computing, artificial intelligence, and behavioral analytics to enhance enterprise value through social graph monitoring. The company provides governance, compliance, and monitoring solutions aimed at improving connectivity, collaboration, and security within organizations. Their platform addresses challenges faced by legal, compliance, information security, and IT departments, offering tools for archiving, monitoring, organizational insights, data loss prevention, eDiscovery, retention, and legal holds. By harnessing insights into human behavior and interactivity, Aware aims to improve employee engagement while minimizing the risk of unsafe behavior in the workplace.

Enable Injections

Series A in 2016
Enable Injections, LLC specializes in the design and manufacture of disposable, body-worn bolus injectors that facilitate the delivery of high viscosity and volume injectable drugs directly into subcutaneous tissue. Established in 2010 and based in Cincinnati, Ohio, the company’s innovative devices can utilize standard containers such as vials, syringes, or cartridges. These injectors not only allow for the reconstitution of powdered drugs but also enable the delivery of up to 20 ml of medication. The system automatically warms and mixes lyophilized solutions, ensuring a seamless injection experience. Additionally, Enable Injections offers a version of its platform that can connect to smartphones via Bluetooth, enhancing user interaction. With approximately 900 new drugs in development that may benefit from this technology, the market for bolus injection systems is projected to reach $8 billion within the next decade.

Spirosure

Series C in 2016
Spirosure develops and manufactures breath-analysis devices aimed at improving disease diagnosis and management through non-invasive technology. The company focuses on chronic respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and chronic pulmonary hypertension. By utilizing advanced sensors and algorithms, Spirosure's devices enable the detection of biomarkers in patients' breath, which assists medical researchers in diagnosing and monitoring these conditions. Additionally, the technology supports the monitoring of medication adherence for asthma patients, contributing to better management of chronic diseases and enhancing preventative healthcare.

DOmedia

Series A in 2016
DOmedia, LLC is an independent technology company based in Columbus, Ohio, that operates a media buying and selling platform focused on out-of-home media. Founded in 2007, the company provides cloud-based applications that facilitate the management of media information, proposal requests, and vendor interactions. Its online marketplace allows media providers to create profiles for their properties, while advertisers and agencies can access a comprehensive database to discover new ideas and efficiently plan out-of-home campaigns. By connecting buyers and sellers, DOmedia aims to streamline processes, reduce labor, and enhance reporting and analytics for agencies, vendors, and brands globally.

DecisionDesk

Debt Financing in 2013
DecisionDesk Inc. is a technology company specializing in application and enrollment management solutions tailored for higher education institutions, fine arts programs, and non-profits. Founded in 2008 and based in Lakewood, Ohio, DecisionDesk streamlines the admissions process through an intuitive platform that facilitates submission, review, and decision-making. The company's offerings include a comprehensive suite of tools such as application management, student dashboards, communication tools, mobile review capabilities, and reporting features. DecisionDesk's solutions encompass an end-to-end admissions system, with functionalities designed to simplify multi-stage evaluation processes and integrate seamlessly with existing campus systems, CRM, and SIS platforms. Additionally, it supports the submission of various digital application materials, including portfolios and video profiles, enhancing the efficiency of admissions workflows. Formerly known as CitizenGroove, Inc., DecisionDesk aims to save institutions time and resources while improving the overall admissions experience.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.